Meeder Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Meeder Advisory Services's NBIX Position: Q2 2026 in Review
Meeder Advisory Services opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 1,439 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #634 among its holdings. This is a return to the name: Meeder Advisory Services previously reported a position in NBIX as recently as Q4 2025.
Meeder Advisory Services first reported a position in NBIX in Q4 2025 and has held it in 2 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.
- Meeder Advisory Services held 1,439 shares of Neurocrine Biosciences worth $243K as of Q2 2026.
- Neurocrine Biosciences was a new Meeder Advisory Services position in Q2 2026.
- Neurocrine Biosciences made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #634 holding.
- Meeder Advisory Services first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 2 quarters since.
- 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.